A viral video of a Wachtell, Lipton, Rosen & Katz partner kissing a younger colleague in Central Park has sent shockwaves through the elite corridors of Big Law. The footage featured attorney
The curtain comes down on the Royal Ascot meeting on Saturday with a seven-race card headlined by the Group One Queen Elizabeth II Jubilee Stakes at 3.40pm. Australia are doubly represented in
More
SpaceX has achieved remarkable things in the aerospace industry, almost singlehandedly lowering the cost of launching payloads into low earth orbit by an order of magnitude. The company’s highly anticipated IPO arrived
More
The UK government is preparing to compel social media platforms to give greater prominence to British news providers as part of a broader effort to combat misinformation online. Ministers are drawing up
More
LegalOn Technologies has partnered with Above the Law to release a practical guide on building AI prompt libraries designed specifically for legal departments. The guide, published in June 2026, addresses a growing
More
The FTSE 100 index and the World Cup share more in common than most investors might expect, with striking parallels between certain stocks and competing nations. Lloyds Banking Group (LSE: LLOY) draws
More
The Class Three Lapis Lazuli Handicap at Sha Tin shapes up as the most difficult puzzle on the card, but finding the winner should pay rich dividends. Andrea Atzeni’s ultra-consistent Enthusium and
More
The 2026 FIFA World Cup is underway across North America, with matches being held in 16 cities spread across the United States, Canada, and Mexico. This marks only the second time in
More
British stocks are frequently overlooked by investors drawn to high-profile American names, but domestic equities have quietly delivered impressive returns. There are currently 42 members of the FTSE 100 that have outperformed
More
The projected economic benefit of Heathrow’s third runway has been dramatically reduced, with new government analysis finding the expansion may boost GDP by just 0.05 per cent. That figure represents a 90
More
uniQure’s gene therapy AMT-130 has been given a renewed shot at regulatory approval after the FDA dramatically reversed its earlier position on the Huntington’s disease treatment. The agency now agrees that uniQure’s
More